Date / Time | Nov. 20 (Sat), 08:30-10:00 | |
---|---|---|
Channel | Channel 3 | |
Chair(s) |
Si Young Song (Yonsei Univ., Korea) Soo Teik Lee (Jeonbuk National Univ., Korea) |
|
Speakers | 08:30-08:52 | Predicting therapeutic efficacy using receptor-targeted activatable probes Ju Hee Ryu (Korea Institute of Science and Technology, Korea) |
08:52-09:14 | Clinical application of proteomics/metabolomics Byong Chul Yoo (National Cancer Center, Korea) | |
09:14-09:36 | Emerging prospects of exosome: Regulation of cancer immune microenvironment Yoosoo Yang (Korea Institute of Science and Technology, Korea) | |
09:36-09:58 | Current and future pharmacological and surgical treatment options for NAFLD Yong Ju Ahn (HuNBiome Co., Ltd., Korea) |
Date / Time | Nov. 20 (Sat), 10:15-11:45 | |
---|---|---|
Channel | Channel 3 | |
Chair(s) |
Seung Woo Park (Yonsei Univ., Korea) Sang Hyub Lee (Seoul National Univ., Korea) |
|
Speakers | 10:15-10:37 | Proteogenomics analysis of human pancreatic ductal adenocarcinoma Daehee Hwang (Seoul National Univ., School of Biological Sciences, Korea) |
10:37-10:59 | Enhancing the immune response to pancreatic cancer: Lessons from the tumor microenvironment Venu G. Pillarisetty (Univ. of Washington, USA) | |
10:59-11:21 | New immuno-oncology agents for patients with pancreatobiliary cancer Rachna Shroff (Univ. of Arizona Cancer Center, USA) | |
11:21-11:43 | Real-world experience of immune checkpoint blockade therapy for pancreatobiliary cancer Hee Seung Lee (Yonsei Univ., Korea) |